Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Mughal ruler Aurangzeb’s grave in Maharashtra’s Khuldabad has become a target of fringe right-wing groups, who are demanding its demolition. The 17th-century emperor is once again back in the news and ...

Giving fans an update about her lifelong struggle with her weight, Rosie O’Donnell has declared she has found her recent ...

Rosie O'Donnell provides an update on her weight loss journey during a TikTok video posted on Thursday, March 20. The Emmy Award winner shares that she has continued to lose weight since starting ...

Rosie O'Donnell is giving an update on her weight loss journey.

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Eli Lilly shares climbed after launching its weight-loss drug, Mounjaro, in India at a steep discount. The drug is now ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...